3D structure of Torpedo californica acetylcholinesterase complexed with huprine X at 2.1 Å resolution:: Kinetic and molecular dynamic correlates

被引:125
作者
Dvir, H
Wong, DM
Harel, M
Barril, X
Orozco, M
Luque, FJ
Muñoz-Torrero, D
Camps, P
Rosenberry, TL
Silman, I
Sussman, JL [1 ]
机构
[1] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel
[2] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel
[3] Univ Barcelona, Fac Farm, Dept Fisicoquim, E-08028 Barcelona, Spain
[4] Univ Barcelona, Fac Quim, Dept Bioquim & Biol Mol, E-08028 Barcelona, Spain
[5] Univ Barcelona, Fac Farm, Quim Farmaceut Lab, E-08028 Barcelona, Spain
[6] Mayo Fdn Med Educ, Mayo Clin, Dept Pharmacol, Jacksonville, FL 32224 USA
[7] Mayo Fdn Med Educ, Mayo Clin, Program Neurosci, Jacksonville, FL 32224 USA
关键词
D O I
10.1021/bi011652i
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Huprine X is a novel acetylcholinesterase (AChE) inhibitor, with one of the highest affinities reported for a reversible inhibitor. It is a synthetic hybrid that contains the 4-aminoquinoline substructure of one anti-Alzheimer drug, tacrine, and a carbobicyclic moiety resembling that of another AChE inhibitor, (-)-huperzine A. Cocrystallization of huprine X with Torpedo californica AChE yielded crystals whose 3D structure was determined to 2.1 Angstrom resolution. The inhibitor binds to the anionic site and also hinders access to the esteratic site. Its aromatic portion occupies the same binding site as tacrine, stacking between the aromatic rings of Trp84 and Phe330, whereas the carbobicyclic unit occupies the same binding pocket as (-)-huperzine A. Its chlorine substituent was found to lie in a hydrophobic pocket interacting with rings of the aromatic residues Trp432 and Phe330 and with the methyl groups of Met436 and Ile439, Steady-state inhibition data show that huprine X binds to human AChE and Torpedo AChE 28- and 54-foid, respectively, more tightly than tacrine. This difference stems from the fact that the aminoquinoline moiety of huprine X makes interactions similar to those made by tacrine, but additional bonds to the enzyme are made by the huperzine-like substructure and the chlorine atom. Furthermore, both tacrine and huprine X bind more tightly to Torpedo than to human AChE, suggesting that their quinoline substructures interact better with Phe330 than with Tyr337, the corresponding residue in the human AChE structure. Both (-)-huperzine A and huprine X display slow binding properties, but only binding of the former causes a peptide flip of Gly 117.
引用
收藏
页码:2970 / 2981
页数:12
相关论文
共 83 条
[1]   SYNTHESIS AND EVALUATION OF TACRINE-RELATED COMPOUNDS FOR THE TREATMENT OF ALZHEIMERS-DISEASE [J].
AGUADO, F ;
BADIA, A ;
BANOS, JE ;
BOSCH, F ;
BOZZO, C ;
CAMPS, P ;
CONTRERAS, J ;
DIERSSEN, M ;
ESCOLANO, C ;
GORBIG, DM ;
MUNOZTORRERO, D ;
PUJOL, MD ;
SIMON, M ;
VAZQUEZ, MT ;
VIVAS, NM .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1994, 29 (03) :205-221
[2]   NEW METHOD FOR PREDICTING BINDING-AFFINITY IN COMPUTER-AIDED DRUG DESIGN [J].
AQVIST, J ;
MEDINA, C ;
SAMUELSSON, JE .
PROTEIN ENGINEERING, 1994, 7 (03) :385-391
[3]   MECHANISM OF INHIBITION OF CHOLINESTERASES BY HUPERZINE-A [J].
ASHANI, Y ;
PEGGINS, JO ;
DOCTOR, BP .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 184 (02) :719-726
[4]  
AXELSEN PH, 1994, PROTEIN SCI, V3, P188
[5]   Synthesis and evaluation of tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease [J].
Badia, A ;
Banos, JE ;
Camps, P ;
Contreras, J ;
Gorbig, DM ;
Munoz-Torrero, D ;
Simon, M ;
Vivas, NM .
BIOORGANIC & MEDICINAL CHEMISTRY, 1998, 6 (04) :427-440
[6]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[7]  
BARON P, IN PRESS BIOCHEMISTR
[8]   Predicting relative binding free energies of tacrine-huperzine A hybrids as inhibitors of acetylcholinesterase [J].
Barril, X ;
Orozco, M ;
Luque, FJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (25) :5110-5119
[9]   THE CHOLINERGIC HYPOTHESIS OF GERIATRIC MEMORY DYSFUNCTION [J].
BARTUS, RT ;
DEAN, RL ;
BEER, B ;
LIPPA, AS .
SCIENCE, 1982, 217 (4558) :408-417
[10]   Effects of metrifonate on cognitive decline in Alzheimer disease: A double-blind, placebo-controlled, 6-month study [J].
Becker, RE ;
Colliver, JA ;
Markwell, SJ ;
Moriearty, PL ;
Unni, LK ;
Vicari, S .
ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1998, 12 (01) :54-57